Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$36,000.00
Jul 1, 2025
For-profit organization
Advancement of a Hypoxia-Activated Reagent for Detection and Mapping of Hypoxia in Cells and Tumors
1032297
Firm proposes commercial advancement of one of the lead candidates that offers time & cost-effective precision imaging and quantification of tumor hypoxia, which will help determine an effective therapy plan for patients and offer socioeconomic benefits.
$15,000.00
Apr 26, 2023
For-profit organization
FR-03555
FR-03555
Develop digital adoption plan
$699,000.00
Sep 26, 2022
For-profit organization
Neuromuscular junction-on-a-chip for rapid diagnosis of neuromuscular diseases and applications in precision medicine
997002
Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates.
$25,000.00
Feb 7, 2018
A Real-Time System for Triggering Muscle Stimulation Based on Electromyography Measurements
EGP
$185,000.00
May 10, 2017
Engineering matrix-derived microcarriers as tissue-specific cell culture and delivery platforms
RGPIN
$349,500.00
Apr 25, 2017
Wireless neurophotonic probes for the interrogation of neurons in memory circuits
CHRPJ
$240,625.00
Apr 25, 2017
Engineering Starch-Based Nanoparticles and Nanoparticle Clusters for Improving Local Drug Delivery to Tumour Cores and the Brain
CHRPJ